Symbol:
Dapk2
Name:
death-associated protein kinase 2
RGD ID:
1304708
Description:
Predicted to enable several functions, including ATP binding activity; calmodulin binding activity; and identical protein binding activity. Predicted to be involved in several processes, including anoikis; positive regulation of granulocyte chemotaxis; and regulation of apoptotic process. Predicted to be located in Golgi apparatus. Predicted to be active in cytoplasm and nucleus. Orthologous to human DAPK2 (death associated protein kinase 2); INTERACTS WITH 2,3',4,4',5-Pentachlorobiphenyl; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
death-associated kinase 2; LOC300799; MGC109553
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 75,601,621 - 75,720,619 (+) NCBI GRCr8 mRatBN7.2 8 66,706,536 - 66,825,567 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 66,706,609 - 66,825,567 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 72,218,993 - 72,338,006 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 70,492,045 - 70,611,049 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 68,362,023 - 68,481,089 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 71,822,107 - 71,941,941 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 71,822,129 - 71,941,910 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 71,490,902 - 71,610,445 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 70,539,831 - 70,566,213 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 70,558,884 - 70,585,265 (+) NCBI Celera 8 66,187,713 - 66,213,741 (+) NCBI Celera Cytogenetic Map 8 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Dapk2 Rat 1,1-dichloroethene increases expression ISO Dapk2 (Mus musculus) 6480464 vinylidene chloride results in increased expression of DAPK2 mRNA CTD PMID:26682919 Dapk2 Rat 1,2-dimethylhydrazine multiple interactions ISO Dapk2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DAPK2 mRNA CTD PMID:22206623 Dapk2 Rat 17beta-estradiol multiple interactions ISO DAPK2 (Homo sapiens) 6480464 EGF protein promotes the reaction [Estradiol results in increased expression of DAPK2 mRNA] CTD PMID:24758408 Dapk2 Rat 17beta-estradiol decreases expression ISO Dapk2 (Mus musculus) 6480464 Estradiol results in decreased expression of DAPK2 mRNA CTD PMID:19484750 and PMID:39298647 Dapk2 Rat 17beta-estradiol increases expression ISO DAPK2 (Homo sapiens) 6480464 Estradiol results in increased expression of DAPK2 mRNA CTD PMID:23373633 more ... Dapk2 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31020377 and PMID:32895711 Dapk2 Rat 2,3',4,4',5-Pentachlorobiphenyl affects expression EXP 6480464 2 more ... CTD PMID:31020377 Dapk2 Rat 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2 more ... CTD PMID:31020377 and PMID:32895711 Dapk2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAPK2 mRNA] CTD PMID:21215274 Dapk2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DAPK2 mRNA CTD PMID:33387578 Dapk2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DAPK2 mRNA CTD PMID:34747641 Dapk2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Dapk2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of DAPK2 mRNA CTD PMID:15310856 more ... Dapk2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Dapk2 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DAPK2 mRNA CTD PMID:25975270 Dapk2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DAPK2 mRNA CTD PMID:21215274 Dapk2 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of DAPK2 mRNA CTD PMID:21346803 Dapk2 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Dapk2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of DAPK2 mRNA CTD PMID:25172293 Dapk2 Rat 3-methylcholanthrene multiple interactions ISO Dapk2 (Mus musculus) 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA CTD PMID:23519560 Dapk2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Dapk2 (Mus musculus) 6480464 bisphenol S results in decreased expression of DAPK2 mRNA CTD PMID:39298647 Dapk2 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of DAPK2 mRNA CTD PMID:21346803 Dapk2 Rat 4-hydroxyphenyl retinamide increases expression ISO Dapk2 (Mus musculus) 6480464 Fenretinide results in increased expression of DAPK2 mRNA CTD PMID:28973697 Dapk2 Rat 5-aza-2'-deoxycytidine increases expression ISO DAPK2 (Homo sapiens) 6480464 Decitabine results in increased expression of DAPK2 mRNA CTD PMID:19037991 Dapk2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of DAPK2 mRNA CTD PMID:24780913 and PMID:25825206 Dapk2 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of DAPK2 mRNA CTD PMID:28959563 Dapk2 Rat aflatoxin B1 decreases expression ISO DAPK2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of DAPK2 mRNA CTD PMID:22100608 and PMID:27153756 Dapk2 Rat aflatoxin B1 decreases methylation ISO DAPK2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of DAPK2 intron CTD PMID:30157460 Dapk2 Rat Aflatoxin B2 alpha decreases methylation ISO DAPK2 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of DAPK2 intron CTD PMID:30157460 Dapk2 Rat all-trans-retinoic acid increases expression ISO DAPK2 (Homo sapiens) 6480464 Tretinoin results in increased expression of DAPK2 mRNA and Tretinoin results in increased expression of DAPK2 protein CTD PMID:15498508 more ... Dapk2 Rat all-trans-retinoic acid multiple interactions ISO DAPK2 (Homo sapiens) 6480464 DAPK2 protein affects the reaction [Tretinoin promotes the reaction [ATG5 protein binds to ATG12 protein]] more ... CTD PMID:28978663 Dapk2 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DAPK2 mRNA CTD PMID:35163327 Dapk2 Rat amiodarone increases expression ISO DAPK2 (Homo sapiens) 6480464 Amiodarone results in increased expression of DAPK2 mRNA CTD PMID:19774075 Dapk2 Rat aristolochic acid A increases expression ISO DAPK2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of DAPK2 mRNA CTD PMID:33212167 Dapk2 Rat arsenous acid increases expression ISO DAPK2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of DAPK2 mRNA and Arsenic Trioxide results in increased expression of DAPK2 protein CTD PMID:28978663 Dapk2 Rat arsenous acid multiple interactions ISO DAPK2 (Homo sapiens) 6480464 DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein] more ... CTD PMID:28978663 Dapk2 Rat benzo[a]pyrene multiple interactions ISO Dapk2 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DAPK2 mRNA] CTD PMID:22228805 Dapk2 Rat benzo[a]pyrene affects methylation ISO DAPK2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of DAPK2 intron CTD PMID:30157460 Dapk2 Rat benzo[e]pyrene increases methylation ISO DAPK2 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of DAPK2 intron CTD PMID:30157460 Dapk2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DAPK2 mRNA CTD PMID:25181051 and PMID:34947998 Dapk2 Rat bisphenol A increases expression ISO Dapk2 (Mus musculus) 6480464 bisphenol A results in increased expression of DAPK2 mRNA CTD PMID:32156529 Dapk2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DAPK2 mRNA CTD PMID:30816183 and PMID:32528016 Dapk2 Rat bortezomib multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of DAPK2 mRNA CTD PMID:25522274 Dapk2 Rat Cacalol increases expression ISO DAPK2 (Homo sapiens) 6480464 cacalol results in increased expression of DAPK2 mRNA CTD PMID:20665104 Dapk2 Rat cadmium dichloride multiple interactions ISO Dapk2 (Mus musculus) 6480464 MT3 affects the reaction [Cadmium Chloride affects the expression of DAPK2 mRNA] CTD PMID:20371981 Dapk2 Rat cadmium dichloride decreases expression ISO DAPK2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of DAPK2 mRNA CTD PMID:38568856 Dapk2 Rat calcitriol multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA CTD PMID:21592394 Dapk2 Rat calcitriol increases expression ISO DAPK2 (Homo sapiens) 6480464 Calcitriol results in increased expression of DAPK2 mRNA CTD PMID:21592394 Dapk2 Rat carbon nanotube decreases expression ISO Dapk2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Dapk2 Rat chlordecone increases expression ISO Dapk2 (Mus musculus) 6480464 Chlordecone results in increased expression of DAPK2 mRNA CTD PMID:33711761 Dapk2 Rat chlorpyrifos increases expression ISO Dapk2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of DAPK2 mRNA CTD PMID:32715474 Dapk2 Rat ciguatoxin CTX1B affects expression ISO Dapk2 (Mus musculus) 6480464 Ciguatoxins affects the expression of DAPK2 mRNA CTD PMID:18353800 Dapk2 Rat cisplatin multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of DAPK2 mRNA CTD PMID:27392435 Dapk2 Rat cisplatin decreases expression ISO DAPK2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of DAPK2 mRNA CTD PMID:27392435 Dapk2 Rat clofibrate decreases expression ISO Dapk2 (Mus musculus) 6480464 Clofibrate results in decreased expression of DAPK2 mRNA CTD PMID:17585979 Dapk2 Rat copper(II) chloride decreases expression ISO DAPK2 (Homo sapiens) 6480464 cupric chloride results in decreased expression of DAPK2 mRNA CTD PMID:38568856 Dapk2 Rat copper(II) sulfate increases expression ISO DAPK2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of DAPK2 mRNA CTD PMID:19549813 Dapk2 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of DAPK2 mRNA CTD PMID:27523638 Dapk2 Rat cyclosporin A decreases expression ISO Dapk2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of DAPK2 mRNA CTD PMID:19770486 Dapk2 Rat diarsenic trioxide increases expression ISO DAPK2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of DAPK2 mRNA and Arsenic Trioxide results in increased expression of DAPK2 protein CTD PMID:28978663 Dapk2 Rat diarsenic trioxide multiple interactions ISO DAPK2 (Homo sapiens) 6480464 DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein] more ... CTD PMID:28978663 Dapk2 Rat Dibutyl phosphate affects expression ISO DAPK2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of DAPK2 mRNA CTD PMID:37042841 Dapk2 Rat dichloroacetic acid increases expression ISO Dapk2 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of DAPK2 mRNA CTD PMID:28962523 Dapk2 Rat diethyl malate affects expression ISO Dapk2 (Mus musculus) 6480464 diethyl malate affects the expression of DAPK2 mRNA CTD PMID:24814887 Dapk2 Rat dioxygen multiple interactions ISO Dapk2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK2 mRNA CTD PMID:30529165 Dapk2 Rat dorsomorphin multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Dapk2 Rat doxorubicin decreases expression ISO DAPK2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of DAPK2 mRNA CTD PMID:29803840 Dapk2 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DAPK2 mRNA CTD PMID:24136188 Dapk2 Rat folic acid multiple interactions ISO Dapk2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DAPK2 mRNA CTD PMID:22206623 Dapk2 Rat folic acid increases expression ISO Dapk2 (Mus musculus) 6480464 Folic Acid results in increased expression of DAPK2 mRNA CTD PMID:25629700 Dapk2 Rat furosemide affects expression EXP 6480464 Furosemide affects the expression of DAPK2 mRNA CTD PMID:17497460 Dapk2 Rat lead diacetate decreases expression ISO DAPK2 (Homo sapiens) 6480464 lead acetate results in decreased expression of DAPK2 mRNA CTD PMID:38568856 Dapk2 Rat methapyrilene increases methylation ISO DAPK2 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of DAPK2 intron CTD PMID:30157460 Dapk2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of DAPK2 gene CTD PMID:35440735 Dapk2 Rat N-nitrosodiethylamine increases expression ISO Dapk2 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of DAPK2 mRNA CTD PMID:24535843 Dapk2 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of DAPK2 mRNA CTD PMID:33484710 Dapk2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK2 mRNA CTD PMID:25729387 Dapk2 Rat p-menthan-3-ol decreases expression ISO DAPK2 (Homo sapiens) 6480464 Menthol results in decreased expression of DAPK2 mRNA CTD PMID:26760959 Dapk2 Rat paracetamol affects expression ISO Dapk2 (Mus musculus) 6480464 Acetaminophen affects the expression of DAPK2 mRNA CTD PMID:17562736 Dapk2 Rat paracetamol increases expression ISO Dapk2 (Mus musculus) 6480464 Acetaminophen results in increased expression of DAPK2 mRNA CTD PMID:17585979 Dapk2 Rat perfluorooctanoic acid increases expression ISO DAPK2 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of DAPK2 mRNA CTD PMID:27153767 Dapk2 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DAPK2 mRNA CTD PMID:35163327 Dapk2 Rat phenytoin decreases expression ISO DAPK2 (Homo sapiens) 6480464 Phenytoin results in decreased expression of DAPK2 mRNA CTD PMID:14741686 Dapk2 Rat phorbol 13-acetate 12-myristate multiple interactions ISO Dapk2 (Mus musculus) 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA CTD PMID:23519560 Dapk2 Rat pirinixic acid decreases expression ISO Dapk2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of DAPK2 mRNA CTD PMID:17426115 Dapk2 Rat pirinixic acid increases expression ISO Dapk2 (Mus musculus) 6480464 pirinixic acid results in increased expression of DAPK2 mRNA CTD PMID:18301758 Dapk2 Rat SB 431542 multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Dapk2 Rat SKF-96365 hydrochloride multiple interactions EXP 6480464 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2 more ... CTD PMID:32895711 Dapk2 Rat sodium arsenite decreases expression ISO DAPK2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of DAPK2 mRNA CTD PMID:38568856 Dapk2 Rat sunitinib increases expression ISO DAPK2 (Homo sapiens) 6480464 Sunitinib results in increased expression of DAPK2 mRNA CTD PMID:31533062 Dapk2 Rat tamibarotene increases expression ISO DAPK2 (Homo sapiens) 6480464 tamibarotene results in increased expression of DAPK2 mRNA CTD PMID:15498508 Dapk2 Rat testosterone multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA CTD PMID:21592394 Dapk2 Rat testosterone increases expression ISO DAPK2 (Homo sapiens) 6480464 Testosterone results in increased expression of DAPK2 mRNA CTD PMID:21592394 Dapk2 Rat titanium dioxide decreases methylation ISO Dapk2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of DAPK2 gene and titanium dioxide results in decreased methylation of DAPK2 promoter CTD PMID:35295148 Dapk2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK2 mRNA CTD PMID:25729387 Dapk2 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of DAPK2 mRNA CTD PMID:25729387 Dapk2 Rat trichostatin A increases expression ISO DAPK2 (Homo sapiens) 6480464 trichostatin A results in increased expression of DAPK2 mRNA CTD PMID:16865256 Dapk2 Rat triclosan increases expression ISO DAPK2 (Homo sapiens) 6480464 Triclosan results in increased expression of DAPK2 mRNA CTD PMID:30510588 Dapk2 Rat triphenyl phosphate affects expression ISO DAPK2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of DAPK2 mRNA CTD PMID:37042841 Dapk2 Rat usnic acid increases expression ISO DAPK2 (Homo sapiens) 6480464 usnic acid results in increased expression of DAPK2 mRNA CTD PMID:32508146 Dapk2 Rat valproic acid increases methylation ISO DAPK2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of DAPK2 gene CTD PMID:29154799 Dapk2 Rat valproic acid increases expression ISO Dapk2 (Mus musculus) 6480464 Valproic Acid results in increased expression of DAPK2 mRNA CTD PMID:21427059 Dapk2 Rat valproic acid decreases expression ISO DAPK2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of DAPK2 mRNA CTD PMID:26272509 Dapk2 Rat valproic acid multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA CTD PMID:27188386 Dapk2 Rat vorinostat multiple interactions ISO DAPK2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA CTD PMID:27188386
1,1-dichloroethene (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,3',4,4',5-Pentachlorobiphenyl (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-methylcholanthrene (ISO) 4,4'-sulfonyldiphenol (ISO) 4-amino-2,6-dinitrotoluene (EXP) 4-hydroxyphenyl retinamide (ISO) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (EXP) acrylamide (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) amiodarone (ISO) aristolochic acid A (ISO) arsenous acid (ISO) benzo[a]pyrene (ISO) benzo[e]pyrene (ISO) bisphenol A (EXP,ISO) bortezomib (ISO) Cacalol (ISO) cadmium dichloride (ISO) calcitriol (ISO) carbon nanotube (ISO) chlordecone (ISO) chlorpyrifos (ISO) ciguatoxin CTX1B (ISO) cisplatin (ISO) clofibrate (ISO) copper(II) chloride (ISO) copper(II) sulfate (ISO) Cuprizon (EXP) cyclosporin A (ISO) diarsenic trioxide (ISO) Dibutyl phosphate (ISO) dichloroacetic acid (ISO) diethyl malate (ISO) dioxygen (ISO) dorsomorphin (ISO) doxorubicin (ISO) flutamide (EXP) folic acid (ISO) furosemide (EXP) lead diacetate (ISO) methapyrilene (ISO) methoxychlor (EXP) N-nitrosodiethylamine (ISO) nitrofen (EXP) oxaliplatin (EXP) p-menthan-3-ol (ISO) paracetamol (ISO) perfluorooctanoic acid (EXP,ISO) phenytoin (ISO) phorbol 13-acetate 12-myristate (ISO) pirinixic acid (ISO) SB 431542 (ISO) SKF-96365 hydrochloride (EXP) sodium arsenite (ISO) sunitinib (ISO) tamibarotene (ISO) testosterone (ISO) titanium dioxide (ISO) topotecan (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) usnic acid (ISO) valproic acid (ISO) vorinostat (ISO)
Dapk2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 75,601,621 - 75,720,619 (+) NCBI GRCr8 mRatBN7.2 8 66,706,536 - 66,825,567 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 66,706,609 - 66,825,567 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 72,218,993 - 72,338,006 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 70,492,045 - 70,611,049 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 68,362,023 - 68,481,089 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 71,822,107 - 71,941,941 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 71,822,129 - 71,941,910 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 71,490,902 - 71,610,445 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 70,539,831 - 70,566,213 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 70,558,884 - 70,585,265 (+) NCBI Celera 8 66,187,713 - 66,213,741 (+) NCBI Celera Cytogenetic Map 8 q24 NCBI
DAPK2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 63,907,036 - 64,046,485 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 63,907,036 - 64,072,033 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 64,199,235 - 64,338,684 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 61,986,288 - 62,125,574 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 15 61,986,288 - 62,125,574 NCBI Celera 15 41,078,636 - 41,217,972 (-) NCBI Celera Cytogenetic Map 15 q22.31 NCBI HuRef 15 41,023,955 - 41,163,206 (-) NCBI HuRef CHM1_1 15 64,318,568 - 64,458,052 (-) NCBI CHM1_1 T2T-CHM13v2.0 15 61,714,186 - 61,853,651 (-) NCBI T2T-CHM13v2.0
Dapk2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 66,065,364 - 66,179,524 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 66,065,505 - 66,179,524 (+) Ensembl GRCm39 Ensembl GRCm38 9 66,158,226 - 66,272,242 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 66,158,223 - 66,272,242 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 66,006,033 - 66,120,049 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 65,956,271 - 66,070,248 (+) NCBI MGSCv36 mm8 Celera 9 63,393,700 - 63,507,514 (+) NCBI Celera Cytogenetic Map 9 C NCBI cM Map 9 35.75 NCBI
Dapk2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955450 11,348,566 - 11,455,582 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955450 11,348,566 - 11,443,908 (+) NCBI ChiLan1.0 ChiLan1.0
DAPK2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 53,162,740 - 53,301,906 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 57,338,037 - 57,477,043 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 42,860,484 - 42,999,489 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 61,152,553 - 61,284,994 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 61,152,553 - 61,284,990 (-) Ensembl panpan1.1 panPan2
DAPK2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 30 28,440,616 - 28,565,089 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 30 28,441,161 - 28,565,566 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 30 28,360,544 - 28,485,020 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 30 28,614,566 - 28,741,234 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 30 28,614,643 - 28,740,679 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 30 28,551,372 - 28,675,829 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 30 28,613,775 - 28,738,321 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 30 28,852,337 - 28,976,558 (-) NCBI UU_Cfam_GSD_1.0
Dapk2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 106,565,063 - 106,678,970 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936471 24,412,029 - 24,527,023 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936471 24,412,035 - 24,527,007 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
DAPK2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 107,997,293 - 108,132,781 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 107,997,274 - 108,131,723 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 118,993,426 - 119,044,831 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
DAPK2 (Chlorocebus sabaeus - green monkey)
Dapk2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 52 Count of miRNA genes: 50 Interacting mature miRNAs: 50 Transcripts: ENSRNOT00000023372 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
1298065 Scl16 Serum cholesterol level QTL 16 3.8 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30856404 75856404 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 30848154 101699754 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 41866876 86866876 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 42692684 90165460 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 30848154 101699754 Rat 1582222 Epfw2 Epididymal fat weight QTL 2 3.2 0.0005 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 8 31737729 76737729 Rat 61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 3.1 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 35582032 80582032 Rat 4889938 Bss89 Bone structure and strength QTL 89 3.8 tibia size trait (VT:0100001) tibia cortical bone volume (CMO:0001725) 8 50095249 82460899 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 30848154 101699754 Rat 1300146 Rf17 Renal function QTL 17 2.9 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 8 28242912 73242912 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 28242912 99525068 Rat 2313088 Bss75 Bone structure and strength QTL 75 3.1 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 8 30848154 82460899 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 27205715 99103503 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 19331152 93965294 Rat 724514 Uae15 Urinary albumin excretion QTL 15 2.9 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 29502665 70386295 Rat 631842 Inf1 Infertility severity QTL 1 4.1 0.001 seminal gland mass (VT:0010524) seminal vesicle wet weight (CMO:0001603) 8 22662330 67662330 Rat 737824 Hcar10 Hepatocarcinoma resistance QTL 10 2.9 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 8 40713066 82925667 Rat 1331769 Rf39 Renal function QTL 39 3.871 urine output (VT:0003620) timed urine volume (CMO:0000260) 8 41866876 75097878 Rat 61358 Bp39 Blood pressure QTL 39 2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 35551938 80551938 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 40713066 93965294 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 27205715 99103503 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 46531639 119088626 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30848259 105647037 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 54237644 85365202 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 27205715 99103503 Rat 631216 Stl9 Serum triglyceride level QTL 9 4.71 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 8 41867010 70386132 Rat 5684973 Bss100 Bone structure and strength QTL 100 4.7 tibia area (VT:1000281) tibia area measurement (CMO:0001382) 8 50095249 82460899 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 54237644 85365202 Rat 2313057 Bss76 Bone structure and strength QTL 76 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 8 30848154 82460899 Rat 12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 43296169 98968765 Rat 1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 54259986 100382532 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 30188867 94457446 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 43296169 98968765 Rat 2313067 Bss77 Bone structure and strength QTL 77 3.1 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 8 30848154 82460899 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 43296169 98968765 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 43296169 98968765 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 43296169 98968765 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 43296169 98968765 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 51351728 107062046 Rat 2313086 Bss60 Bone structure and strength QTL 60 4.1 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 8 50095249 82460899 Rat 2303171 Bp331 Blood pressure QTL 331 5.57 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 61290298 119084929 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 54043744 98968765 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 46531722 99083736 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 36469535 99083736 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 631653 Bp125 Blood pressure QTL 125 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 66142385 111142385 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 631271 Lecl1 Lens clarity QTL 1 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 8 18984168 84531599 Rat 2303564 Gluco43 Glucose level QTL 43 3 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 8 26130187 71130187 Rat 2303570 Gluco48 Glucose level QTL 48 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 8 49805831 94805831 Rat 2313046 Bss78 Bone structure and strength QTL 78 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 8 30848154 82460899 Rat 2303572 Insul13 Insulin level QTL 13 2 blood insulin amount (VT:0001560) blood insulin level (CMO:0000349) 8 26130187 71130187 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 54237644 99103503 Rat
RH129839
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 66,825,313 - 66,825,493 (+) MAPPER mRatBN7.2 Rnor_6.0 8 71,941,688 - 71,941,867 NCBI Rnor6.0 Rnor_5.0 8 71,610,192 - 71,610,371 UniSTS Rnor5.0 RGSC_v3.4 8 70,565,960 - 70,566,139 UniSTS RGSC3.4 Celera 8 66,213,488 - 66,213,667 UniSTS RH 3.4 Map 8 839.5 UniSTS Cytogenetic Map 8 q24 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000023372 ⟹ ENSRNOP00000023372
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 8 71,914,867 - 71,941,409 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000089147 ⟹ ENSRNOP00000070087
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 66,706,640 - 66,825,567 (+) Ensembl Rnor_6.0 Ensembl 8 71,822,129 - 71,941,910 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000098258 ⟹ ENSRNOP00000085631
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 66,706,609 - 66,813,431 (+) Ensembl
RefSeq Acc Id:
NM_001013109 ⟹ NP_001013127
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,694,648 - 75,720,619 (+) NCBI mRatBN7.2 8 66,799,592 - 66,825,567 (+) NCBI Rnor_6.0 8 71,914,769 - 71,941,941 (+) NCBI Rnor_5.0 8 71,490,902 - 71,610,445 (+) NCBI RGSC_v3.4 8 70,539,831 - 70,566,213 (+) RGD Celera 8 66,187,713 - 66,213,741 (+) RGD
Sequence:
GAGCAGGAACCCCACCCTAACCCCACAGGAAAACACAAAATAACACTTTAATTACTATCTTGCCTTCTTTCTGTTTTGTTCTGCAGCCAGAAAACATTATGTTGTTAGACAAGAATATCCCCATTCCA CACATCAAGCTGATTGACTTTGGCTTGGCTCACGAAATAGAAGATGGAGTTGAATTTAAAAACATTTTTGGGACACCTGAATTTGTTGCTCCAGAAATCGTGAACTATGAGCCACTGGGACTGGAGGC AGACATGTGGAGCATCGGAGTCATCACCTACATCCTTCTAAGTGGAGCATCCCCCTTCCTGGGAGACACAAAGCAAGAAACCCTGGCAAACATCACTGCTGTGAGTTACGACTTTGACGAGGAATTCT TCAGCCAGACCAGTGAGCTGGCCAAGGACTTCATTCGGAAGCTTCTTGTGAAGGAGACCCGGAAACGGCTTACCATCCAAGAGGCTCTCAGGCATCCCTGGATCATGCCAGTGGACAACCAGCAAGCC ATGGTGCGCAGAGAGTCTGTGGTCAACCTGGAGAACTTTAAGAAGCAGTATGTCCGCAGGCGGTGGAAGCTGTCCTTCAGCATCGTCTCCCTGTGCAACCACCTCACTCGCTCCCTGATGAAGAAGGT GCACTTGAGGACAAGTGAGGACCTGAGGAACTGCGAGAGTGACACGGAGGAGAACATTGCCAGGAGGAAAGCCCTTCACCCCCGGAGGAGGAGCAGTACCTCCTAACTGATCCGGCACCTGCTTGTCA CCAGGATCCAGACATTTTGTGTTCCTGAGCACTTTGCAAGAGAGAGGAGTCTGCAGGACTCAGAACTTTCAGGAGACCCTGGGAGTTGTGGCTATCTCCTGGTGGGGAGCCTCCAGCATTCCTCAAGC TCTTAGTTCTCCAGAAAACTGGCTTTCATCTGTCTGCTAACCTCAGAAGCTGGGAATGGGTGTGGACTGAGGAAATGGATCTCAAGGAATATCGTGGTTGTTGTTGTTGTTGTTGTTTTTACCACAGG TTAAAGGTCAGATTTAGGCAGCTTTCCTCACAAGGTGACAGAGTACAGAACCAACTGGTGTAGCAGCCATACCAGGAAGACAAGCCTACCCTATCAGAGTAAAGACTCTCTAGAGTGAGGGACCAATC CTGTGACTTTACAAGAATCCATAAGGAGTCAGGCTGTCTCATGTCAGACTGTGTCTGCCAGCCTCTTGCCAGCTCACTGTGTTGTTTTTTTTCTCATTTTTATTATTAAACTTCTTGTTTATCTAAAA AAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NM_001395735 ⟹ NP_001382664
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,601,672 - 75,720,619 (+) NCBI mRatBN7.2 8 66,706,590 - 66,825,567 (+) NCBI
RefSeq Acc Id:
XM_008766241 ⟹ XP_008764463
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,601,647 - 75,711,542 (+) NCBI mRatBN7.2 8 66,706,562 - 66,816,333 (+) NCBI Rnor_6.0 8 71,822,107 - 71,931,508 (+) NCBI
Sequence:
GGCTCTGCGGGCGGACGCCGGGCTCAGGGAGCAGAGCTGAGAGGATCGCCGCGCACCCCGCCGC GCCCCGGCGCACGTCCTGCCCTCCGCACATGCAGCGCAGCCTCTCGCCGATTGCGTGGTCCAGGCCTCAATGAGGAGTCCAAATATGGAGACATTCAAACAGCAGAAGGTGGAGGACTTCTATGACAT CGGAGAGGAGCTGGGCAGTGGCCAGTTCGCCATCGTGAGGAAGTGCCGGGAGCAGAGCACGGGGCTAGAGTACGCAGCCAAATTCATCAAGAAGAGGCAGAGCCGGGCCAGCCGTCGGGGCGTGTGCC GGGAGGAAATCGAGCGGGAGGTGAGCATCCTGCGGCAGGTGCTGCACCCCAACATCATCACGCTGCACGACGTCTATGAGAACCGCACCGATGTGGTGCTCATCCTTGAGCTAGTTTCCGGAGGAGAA CTGTTCGATTTCTTGGCCCAGAAGGAGTCGTTAAGTGAGGAGGAAGCCACCAGCTTCATTAAGCAGATCCTGGATGGGGTGAATTACCTTCATACAAAGAAAATTGCTCACTTTGATCTCAAGCCAGA AAACATTATGTTGTTAGACAAGAATATCCCCATTCCACACATCAAGCTGATTGACTTTGGCTTGGCTCACGAAATAGAAGATGGAGTTGAATTTAAAAACATTTTTGGGACACCTGAATTTGTTGCTC CAGAAATCGTGAACTATGAGCCACTGGGACTGGAGGCAGACATGTGGAGCATCGGAGTCATCACCTACATCCTTCTAAGTGGAGCATCCCCCTTCCTGGGAGACACAAAGCAAGAAACCCTGGCAAAC ATCACTGCTGTGAGTTACGACTTTGACGAGGAATTCTTCAGCCAGACCAGTGAGCTGGCCAAGGACTTCATTCGGAAGCTTCTTGTGAAGGAGACCCGGAAACGGCTTACCATCCAAGAGGCTCTCAG GCATCCCTGGATCATGTCAAAAGGAGAAGCCAGCGTCCCTGAGCAGTGGAAGACACAACCTGCCCAGCTGAAGACCAAACGCCTAAGAGAGTATACCCTCAAATGCCACTCCAGCATGCCCCCCAACA ACACTTATGTCAACTTTGAACGTTTTGCTCACGTAGTAGAGGATGTGGCTCGGGTAGACGAGGGATGCCATGCCCTCGCAGGAGCCCATGATACCCTGCAGGATGATGTGGAGTCTTTGGTCTCCATC TACAATGAGAAGGAGGCTTGGTACCGAGAGGAGAACGAGAATGCCCGTCATAACCTGTCCCAGCTCAAGTATGAGTTCCGCAAGGTGGAGTCCCTGAAGAAGCTTCTGAGAGAAGACATCCAGGCCGC AGGGGCCAGCCTTGGAGGTGTGGCCAGGAAGCTAGACCATCTGCAGGTGCAGTTTGAGACTCTGAGGCAGCAGCTGTCAGCAGACATTCAGTGGATGCAGGAAATGGCGGGCATACTCCAGCTGGAGA GTGGGAACACTGACGGCCACGCCTTGGGCTCCGTGTTCCACCGGGACACCAGTGAGTCCCTACCAGAGCTGCTCAACAGATCACACACGGAGGGGATCCTGGCCGGCTTGAATCTCTGAGCACCAGGA TCTAGTCAGTAGTGCATTCCCAGGGTTTTGTAGAAGCATGCTGTCTTCCCCTCTGCTGGTGCATCTAGCTGGAAGTGTCGTGCAGGGTGTGTGTTTGCAGCCTTCACTGCCTCTAGAGTTCCCCAGCC ACTGGGGTCTTAGTTAGTTAGTGGACCTACTCCGCACCTCCCTCACCAGCCTAGTTTTCTGAGAGAGTGCTGGCAAAGCAGCTGAGCTGTGGAAACGATGAGAAAACCTATCCCCTCAGCATGCCCTT CTCTGGGGGTATCTTCCGGGCCCCAGGAAATGCTGTATAACTGGGTAATGATGACGGATTGGCTCATCTCTCACATTCCACATGCATGGTGTCTGAGCGAAGATCTTGGATGGACATAGCTAGCATAA CTTGCTCAGCAGTACCTTCCTGTTACAGAGTCAGGGCCTTATAGTACACAGAAAATGTTAAGTTCCTTTTGAGTTGTCTTCTCACTCATTGGGTTTTATGACTGTGACCTTACTGGATGCTTAAGGAA CTCTAAGGGGCTGGGATATAGGTCAGTTTCTAGAGTGCTTGCCCAGCATCCACAGAGCCCTGGGTTTGATGCCCTGCATAGCATGAAGTAGGCTCGGTGATACATACTTCTATTCCTGGGATTTAAGA GGAGTCAGAAGGATCGAGAGTTCAGAGTCATCTCTGACTATATATTGAGTTTGAGTTAAAGGCCAGCCTAGGCTATATGACACCCTGTCTTGGGGTGGGTCAGGGCTCTGTGAGCGGAGAATAAGGAC AGTATTATTACTGTTCATTTCCCATAACTGATGAAGAAGTTGACACAGAGATGGAGAATTGGCATAGGAGCGTTCACAGCCAGTTGCCTTCCCAGGGTGTTCATCTTTGAGGTGCGATATGGAGGAAG AAGTTTAGTGAGGTTTAGCTGTAAATATCCATCTTGATATTAGAGTTCAGATCCCAGAGGCTAAGGGTCTGACTTTATATTGAGGATGAAGACAAGAGACATACAACAAGGATGTATTTATTCCTGTA TAGTAGGCCAGTGGGCCTTGAAGCCTGGCAAACCCCAGAGAGCTTTGAGAAGCACGGGGCTCATTGGTCTCTTCTAGCTCCCAAACTTCATAGCGTGATGTCATCTCCCCTTCCTAGGAGGAAGGCCA ATGCATCCATGCAGACAGCACATAGACTATGGACCTTGGACCCCACATGGAACTAAAAGCTTGGGACTAGGGGCCAACTGCATCACTTCAAGTACCTCCATAGCCTCACAAAATACCCAGAGATATTA TCCCCAGGTTAGGGAGGAAACCAAGAAAGAATGTGACTTGTCCTGTGTCACATTAGTGATAACAATGGGAGCCTTCTGGTGAGTCTGTCACTCTTCCTGATTTCCTTAACTACGTGGACTTTAGGAAT TGATTCTGTGCTTGAGGAAGTGGATGGGACCCAAGCTCATCCATCCATTCAGACATAGTTAGCAGGCACCTGCCAGTTTCAAAAAAGTTGACTCGAGTCTGGGGATGTGATGTTATGTAACATCAAGT CAGTTTTCCTTGGAGTTCTCAGTTAAATGATAGATTCTAGCATTACTCAAGAATTATACAAATGAAGAACTCCAGCTGGTTCCTATGCTGTGAAAGAGAAGGGGGCAACATTGTAAGGCCTGGAGAGA GAGATGGAGGGAGGAAGGGAGGGGTGTAGAGATAGATACATGATAGCTAGATAATTGGGTTGATCTGCTTAGGCAACTATGTATGGAGGACATGGGCTGTGGCCAACTAAGCAAACCTGGGAGAGAGC TGTCCCCTGTAGACTGTCATGCCATGTAGACTGTGATGATGAGAAGGGAATGAAAGGAAAATCAAAATAGAGAGAATGGTATGTACACTGTAGAGACCAGGTGTGTACACTGTAGAGAGCAGGTGTGT ACACTGTAGAGAGCAGGTATGTACACTGTAGAGAGCAGGTATGTACACTGTAGAGAGCAGGTGTGTACACTGTAGAGAGCAGGTGTGTACACTGTAGAGAGCAGGTATGTACACTGTAGAGAGCAGGT GTGTACACTGTAGAGAGCAGGTATGTACACTGTAGAGAGCAGGTGTGTACACTGTAGAGAGCAGGTGTGTACACTGTAGAGAGCAGGTGTGTACACTGTACAGAGCAGGTGTGTACACTGTAGAGAGC AGGTGTGTACACTGTAGAGGGCAGGTGTGTACACTGTAGAGAGCAGGTATATATACTGTAGAGCGAGCTGAGGAAGAGCAGAACCAGCAAGGCCTGTTGAGTTCTACCTTTGCTCCCAGGGTCACCAG AAGCCATTAACAGGTCCTGGGCTAGTGTTGAAGTAGAAATTCTCAGCAGGCAGCACAGACTAGATTTTGATCTAATAAACTCATTCTCTAGAATCCTTTTTTAAAATTAGCAAGCTGGATCATTTAAG GTATCACATATAATAACTGAAATAGAAACTATTTTAATCAAGTATAAGAAACCACAATTTTAAGATGCATGGTTATTTCACGGACAATTAAGGAAGAAAAGCATCCTATCATGGGCAGTCTTGTAGGA GATGCACAGGGAGAGGGCAAACAAGAGACAGCACCACCACGCAGAAGAGGGTGCAAACACACCCGGCTCAACTTTGACCCTAGGTAGAGACAGTAAAACGTGGAGGAGGAGGCCTGGCTACATTTGCA ACATTGCTCTCTGGGTTTGGGCCACATTGGTGTGAACCAGAAGAACTTCAAGCATGGACTGCTGTGGCCCACAGTCGAAGGCTGGGTGACCCCACCTGACTCACTGAGGCTGTGCAGTCCACTCTCCC AATGACCTGCCTCACTTCAGGCCCACAGTGCTGAGATGCCGTGTTGACTGGGAGTTTGACGATGATGGCTGTGGTTTGACGTTGCACATCCAGGGATGAAGGAAAGGCTGCAGAACCCTGTGCCTGAC GCTAAAGACAAATGACTCCACAGATGCTTCCAAGTCCCATGTGCCCTGTTCACATACGTGTTTGGTACAAGACACCATGGATATTAAAGGTCCTTTTGGGTGTATCAACAGACCCTGACATTTACATT GGGTTTCCTAAAAAGAGAACGGCCATGGGTGCAAGATGCTGGATGAACCTTCTCTGAAGGCCAAAGTAAATGCAAGAAGATTTAAGTGATGGCCATGATTTGATTAGGGAGGATGGGAAGGGAGAGAG AGAGCTGGTTTTCTTGGGTTTGTGGAATCTACTACTCTGTTCATGCTGAAAGGGTCCTCGGAGGGGAGCTCCCCAGAACTCTCCCTGTACAGCAGTTTGTGGGATGGCACTTATCCAAGGTCACACAG CTGGTCAGCCTCTGGCCTGGCTCAGAGCCATAGTGGTTTCCTTCCTTGCAGTGAAATTTTCCTCTGTGTTCAGGGCTGGTCATAAGTACAGTGCCTCCTTACCTGTTTCTTTTTTTTTTTTTTTTTTT CTTTTTTTCGGAGCTGGGGACCGAACCCAGGGCCTTGCGTTTGCTAGGCAAGCGCTCTACCACTGAGCTAAATCCCCAACCCTCCTTACCTGTTTCATAACCGGAGTCTTAACTGGACAAAGACAAAG TTAACTACGAAAAGAGCCCAGAGACTTTCAGGGAACTTAGAGGAGACTGTGACCTTCCTATGTCACGACACACAAACTCCTTTCTCCTAAGGTATCACAACCTGATGCGCCGGGGTAACTGAGGAGAC CCGGGAAAGGAGTGCAGTCAGTGAACCTGCTTGCTCCTTATGGGCACACGGATGGCATTTTAATAGCCACCTAGAGCACAGGGCTGTCACGGCAGGATGGGGGATAGGGAGTGGAGTGCTTCACCAGG ACCTAGAGGAAGGGAGCTGGGAACAGGGAGCAGCTCACTGATTTGAGTCTCTGTCACCCTGGGATACTTACATACGGGGGTACAAATATGTGTATAGGTACATTTTATACATATGTATATGCCTGTGG AAGCCAGTGGTCAACCTTGATTGTCATTTCTCTGGAGCTATCTTCCGTGGCTTATTTTCAAGAGAGAGTCTCTGGCTGTGTAGCCCTGGCAGACCTGAGACTCATGATGCAGACCAGGTTGGCCTCCA GTAGAGATCTACCCCTCTGTGTTAGGATCCAAGTCATGTGCCACCACTCCCAGCTTAGCCACCTTGCTTTTTGAGACCTCATAGGGACCACATAGACCAGGCTGGCTGGCCACTGAGCCCTAGGGATC TGCTTCATTTGACCTCCAAGGCACTGGGGATACAAGTGCACACCACTGAGCCTGGCCTTTTACCTGGGGATCAATCGCAGGTCCTCATGTTAGTGCAATCAGCGCTTTGCTGGCTAAGATATCCCCCA GACCCTCACGAAAGATTTTTAATTTACCAGACTTTAAATTAAAGCTTGGCTTCGTGCTCAGTTCAAACATCATTTAGGCTGTCAGGAGGGCAGGGAAAGTGTATAACATATCCCCGAAAATCAGTTCC TAAGGAAGTTGGGAGGCAGGTCCTTGGGCAGGAAGCTGTCCTAGCCTGAAGCAGATACAACTATGGCTGCCCTGTGTGTGTCGGGAAGGGCAGCCACACTCGGCAGTGGATGGTTGTGCAGATTCTGA AGACTCATGAGAAAGAGTTGGAGCAGAGCAGAGGGAATGATCACAGTGTGAAGAGCAGAGACTCCTCCTCTGCTTCTCCTCCTGAGGCGACGATGACAGGGGTAGCTTCCCTTCTCACAGCCCAGTCA GAGGTTGCTGTGTGCCCGGATATAACCGTTTCATCACTGTCAAATCTTCTAGAAATGTCTGTGGAGCTGAATGGCTTTTCTCCTTTGTGAACTTCTTGGCCTGTGGGGACGGTTCTTGCCCTGGAGAC TAAAACTAGTGGTGGGCATGTTGGAGTTGCAAAGGGGCCGGTTCAGTTGAACAAACACCCATTGTGTTCTGGTTCTAGGGGGAGGTGACAGATGAGGTCATGAAAACCCTGAATGAGAGGTTGATAGG GAGAGATATTTTCTTTAATGATGTAGTCACTGGTAAACCTATCCAGGCTCATGTGAACAGCCTCATGCGTCTCACTGGGACACACACACACTCACGCTCACACACTCACACACACACACACACACACA CACACACACACACACACACACGAGGGGCTCTAGTTAGAAAGTGGAAGGGGATTAGTAAAAGAGTGGAGAAGGATTAATGGGGTGTGTATGTGTGTGTGAATGTGATTGGAAATACATTATGTTCATGT CTGAAAATGTCATAATGAAATCCTTTACTACAAATAATGTATGCTAATAAAAATATTTAAAAATTTA
hide sequence
RefSeq Acc Id:
XM_039081122 ⟹ XP_038937050
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,601,621 - 75,711,542 (+) NCBI mRatBN7.2 8 66,706,536 - 66,816,333 (+) NCBI
RefSeq Acc Id:
XM_039081125 ⟹ XP_038937053
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,668,122 - 75,711,542 (+) NCBI mRatBN7.2 8 66,773,055 - 66,816,333 (+) NCBI
RefSeq Acc Id:
XM_039081126 ⟹ XP_038937054
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,668,208 - 75,711,542 (+) NCBI mRatBN7.2 8 66,773,151 - 66,816,333 (+) NCBI
RefSeq Acc Id:
XM_063265164 ⟹ XP_063121234
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 75,601,656 - 75,720,071 (+) NCBI
RefSeq Acc Id:
NP_001013127 ⟸ NM_001013109
- Peptide Label:
isoform 2
- UniProtKB:
Q5BJN2 (UniProtKB/TrEMBL), F1LS59 (UniProtKB/TrEMBL)
- Sequence:
MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP WIMPVDNQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRRSSTS
hide sequence
RefSeq Acc Id:
XP_008764463 ⟸ XM_008766241
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6GD46 (UniProtKB/TrEMBL)
- Sequence:
MRSPNMETFKQQKVEDFYDIGEELGSGQFAIVRKCREQSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF IRKLLVKETRKRLTIQEALRHPWIMSKGEASVPEQWKTQPAQLKTKRLREYTLKCHSSMPPNNTYVNFERFAHVVEDVARVDEGCHALAGAHDTLQDDVESLVSIYNEKEAWYREENENARHNLSQLK YEFRKVESLKKLLREDIQAAGASLGGVARKLDHLQVQFETLRQQLSADIQWMQEMAGILQLESGNTDGHALGSVFHRDTSESLPELLNRSHTEGILAGLNL
hide sequence
Ensembl Acc Id:
ENSRNOP00000070087 ⟸ ENSRNOT00000089147
Ensembl Acc Id:
ENSRNOP00000023372 ⟸ ENSRNOT00000023372
RefSeq Acc Id:
XP_038937050 ⟸ XM_039081122
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6GD46 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038937053 ⟸ XM_039081125
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_038937054 ⟸ XM_039081126
- Peptide Label:
isoform X3
Ensembl Acc Id:
ENSRNOP00000085631 ⟸ ENSRNOT00000098258
RefSeq Acc Id:
NP_001382664 ⟸ NM_001395735
- Peptide Label:
isoform 1
- UniProtKB:
A6J5H8 (UniProtKB/TrEMBL), A0A0G2JX07 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063121234 ⟸ XM_063265164
- Peptide Label:
isoform X4
RGD ID: 13696086
Promoter ID: EPDNEW_R6610
Type: initiation region
Name: Dapk2_1
Description: death-associated protein kinase 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 8 71,822,139 - 71,822,199 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-08-01
Dapk2
death-associated protein kinase 2
Dapk2
death-associated kinase 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-12-06
Dapk2
death-associated kinase 2
Dapk2_predicted
death-associated kinase 2 (predicted)
Symbol and Name updated
1559027
APPROVED
2005-01-12
Dapk2_predicted
death-associated kinase 2 (predicted)
Symbol and Name status set to approved
70820
APPROVED